This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Peripheral Drug Eluting Balloons Market

Market Study on Peripheral Drug Eluting Balloons: Paclitaxel Drug Coating Accounts for Close to 50% Market Share

Peripheral Drug Eluting Balloons Market Segmented By superficial femoral artery, popliteal lesions, infra-popliteal lesions, in-stent restenosis

- Table of Content -

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Drug Coating Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption/ Usage Analysis, by region

    4.2. Regulatory Scenario

    4.3. Technology Assessment

    4.4. Value Chain Analysis

    4.5. Recent Product Approvals and Launches

    4.6. Porter’s Analysis

    4.7. Product USP Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

        5.1.3. Global Peripheral Vascular Devices Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growth in Healthcare Spending

        5.2.2. Growth in Geriatric Population

        5.2.3. Rising Number of Peripheral Surgeries

        5.2.4. Technological Advancements

        5.2.5. Regulatory Landscape

        5.2.6. Cost of Procedures

        5.2.7. Product Adoption Rate and Demand

        5.2.8. Increase in Research and Development

        5.2.9. Pharmaceutical Industry Consolidation Activities

        5.2.10. Top Companies’ Historical Growth

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Drug Coating

        6.1.2. By Indication

        6.1.3. By Artery Type

        6.1.4. By End User

        6.1.5. By Region

    6.2. 2022 Market Scenario

7. Global Market Demand in Volume (Units) Analysis 2012–2022 and Forecast, 2023–2033

    7.1. Historical Market Volume (Units) Analysis, 2012–2022

    7.2. Current and Future Market Volume (Units) (Units) Projections, 2023–2033

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Drug Coating

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2012-2022 and Forecast, 2023-2033

    9.1. Historical Market Value (US$ Mn) Analysis, 2012-2022

    9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

    9.3. Revenue Opportunity Scenario

10. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Drug Coating

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Drug Coating, 2012-2022

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Drug Coating, 2023-2033

        10.3.1. Paclitaxel Drug Coating

        10.3.2. Sirolimus drug Coating

        10.3.3. Others

    10.4. Market Attractiveness Analysis, by Drug Coating

11. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2012-2022

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2023-2033

        11.3.1. Peripheral Arterial Disease

        11.3.2. Peripheral Aneurysms

        11.3.3. In-Stent Restenosis

        11.3.4. Others

    11.4. Market Attractiveness Analysis, by Indication

12. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Artery Type

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis, By Artery Type, 2012-2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Artery Type, 2023-2033

        12.3.1. Carotid Artery

        12.3.2. Fem-Pop Artery

        12.3.3. Iliac Artery

        12.3.4. Infrapop Artery

    12.4. Market Attractiveness Analysis, by Artery Type

13. Global Market Analysis 2012-2022 and Forecast 2023-2033, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2022

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2023-2033

        13.3.1. Hospitals

        13.3.2. Ambulatory Surgical Centers/Outpatients

        13.3.3. Cardiac Catheterization Labs

    13.4. Market Attractiveness Analysis, by End User

14. Global Market Analysis 2012-2022 and Forecast 2023-2033, By Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2012-2022

    14.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, By Region, 2023-2033

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa (MEA)

    14.4. Market Attractiveness Analysis, by Region

15. North America Market Analysis 2012-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    15.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        15.3.1. By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Drug Coating

        15.3.3. By Indication

        15.3.4. By Artery Type

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Coating

        15.4.3. By Indication

        15.4.4. By Artery Type

        15.4.5. By End User

    15.5. PESTLE Analysis

    15.6. Market Trends

    15.7. Key Market Participants – Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

    15.9. Country Level Analysis & Forecast

        15.9.1. U.S. Market Analysis

            15.9.1.1. Introduction

            15.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                15.9.1.2.1. By Drug Coating

                15.9.1.2.2. By Indication

                15.9.1.2.3. By Artery Type

                15.9.1.2.4. By End User

        15.9.2. Canada Market Analysis

            15.9.2.1. Introduction

            15.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                15.9.2.2.1. By Drug Coating

                15.9.2.2.2. By Indication

                15.9.2.2.3. By Artery Type

                15.9.2.2.4. By End User

16. Latin America Market Analysis 2012-2022 and Forecast 2023-2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    16.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        16.3.1. By Country

            16.3.1.1. Mexico

            16.3.1.2. Brazil

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Drug Coating

        16.3.3. By Indication

        16.3.4. By Artery Type

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug Coating

        16.4.3. By Indication

        16.4.4. By Artery Type

        16.4.5. By End User

    16.5. PESTLE Analysis

    16.6. Market Trends

    16.7. Key Market Participants – Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

    16.9. Country Level Analysis & Forecast

        16.9.1. Mexico Market Analysis

            16.9.1.1. Introduction

            16.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                16.9.1.2.1. By Drug Coating

                16.9.1.2.2. By Indication

                16.9.1.2.3. By Artery Type

                16.9.1.2.4. By End User

        16.9.2. Brazil Market Analysis

            16.9.2.1. Introduction

            16.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                16.9.2.2.1. By Drug Coating

                16.9.2.2.2. By Indication

                16.9.2.2.3. By Artery Type

                16.9.2.2.4. By End User

        16.9.3. Argentina Market Analysis

            16.9.3.1. Introduction

            16.9.3.2. Market Analysis and Forecast, by Market Taxonomy

                16.9.3.2.1. By Drug Coating

                16.9.3.2.2. By Indication

                16.9.3.2.3. By Artery Type

                16.9.3.2.4. By End User

17. Europe Market Analysis 2012-2022 and Forecast 2023-2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    17.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Nordic Countries

            17.3.1.9. Rest of Europe

        17.3.2. By Drug Coating

        17.3.3. By Indication

        17.3.4. By Artery Type

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Drug Coating

        17.4.3. By Indication

        17.4.4. By Artery Type

        17.4.5. By End User

    17.5. PESTLE Analysis

    17.6. Market Trends

    17.7. Key Market Participants – Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

    17.9. Country Level Analysis & Forecast

        17.9.1. Germany Market Analysis

            17.9.1.1. Introduction

            17.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.1.2.1. By Drug Coating

                17.9.1.2.2. By Indication

                17.9.1.2.3. By Artery Type

                17.9.1.2.4. By End User

        17.9.2. Italy Market Analysis

            17.9.2.1. Introduction

            17.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.2.2.1. By Drug Coating

                17.9.2.2.2. By Indication

                17.9.2.2.3. By Artery Type

                17.9.2.2.4. By End User

        17.9.3. France Market Analysis

            17.9.3.1. Introduction

            17.9.3.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.3.2.1. By Drug Coating

                17.9.3.2.2. By Indication

                17.9.3.2.3. By Artery Type

                17.9.3.2.4. By End User

        17.9.4. U.K. Market Analysis

            17.9.4.1. Introduction

            17.9.4.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.4.2.1. By Drug Coating

                17.9.4.2.2. By Indication

                17.9.4.2.3. By Artery Type

                17.9.4.2.4. By End User

        17.9.5. Spain Market Analysis

            17.9.5.1. Introduction

            17.9.5.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.5.2.1. By Drug Coating

                17.9.5.2.2. By Indication

                17.9.5.2.3. By Artery Type

                17.9.5.2.4. By End User

        17.9.6. BENELUX Market Analysis

            17.9.6.1. Introduction

            17.9.6.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.6.2.1. By Drug Coating

                17.9.6.2.2. By Indication

                17.9.6.2.3. By Artery Type

                17.9.6.2.4. By End User

        17.9.7. Russia Market Analysis

            17.9.7.1. Introduction

            17.9.7.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.7.2.1. By Drug Coating

                17.9.7.2.2. By Indication

                17.9.7.2.3. By Artery Type

                17.9.7.2.4. By End User

        17.9.8. Nordic Countries Market Analysis

            17.9.8.1. Introduction

            17.9.8.2. Market Analysis and Forecast, by Market Taxonomy

                17.9.8.2.1. By Drug Coating

                17.9.8.2.2. By Indication

                17.9.8.2.3. By Artery Type

                17.9.8.2.4. By End User

18. East Asia Market Analysis 2012-2022 and Forecast 2023-2033

    18.1. Introduction

    18.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2012-2022

    18.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Drug Coating

        18.3.3. By Indication

        18.3.4. By Artery Type

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Drug Coating

        18.4.3. By Indication

        18.4.4. By Artery Type

        18.4.5. By End User

    18.5. PESTLE Analysis

    18.6. Market Trends

    18.7. Key Market Participants – Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

    18.9. Country Level Analysis & Forecast

        18.9.1. China Market Analysis

            18.9.1.1. Introduction

            18.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                18.9.1.2.1. By Drug Coating

                18.9.1.2.2. By Indication

                18.9.1.2.3. By Artery Type

                18.9.1.2.4. By End User

        18.9.2. Japan Market Analysis

            18.9.2.1. Introduction

            18.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                18.9.2.2.1. By Drug Coating

                18.9.2.2.2. By Indication

                18.9.2.2.3. By Artery Type

                18.9.2.2.4. By End User

        18.9.3. South Korea Market Analysis

            18.9.3.1. Introduction

            18.9.3.2. Market Analysis and Forecast, by Market Taxonomy

                18.9.3.2.1. By Drug Coating

                18.9.3.2.2. By Indication

                18.9.3.2.3. By Artery Type

                18.9.3.2.4. By End User

19. South Asia Market Analysis 2012-2022 and Forecast 2023-2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    19.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        19.3.1. By Country

            19.3.1.1. India

            19.3.1.2. Indonesia

            19.3.1.3. Malaysia

            19.3.1.4. Thailand

            19.3.1.5. Rest of South Asia

        19.3.2. By Drug Coating

        19.3.3. By Indication

        19.3.4. By Artery Type

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Drug Coating

        19.4.3. By Indication

        19.4.4. By Artery Type

        19.4.5. By End User

    19.5. PESTLE Analysis

    19.6. Market Trends

    19.7. Key Market Participants – Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

    19.9. Country Level Analysis & Forecast

        19.9.1. India Market Analysis

            19.9.1.1. Introduction

            19.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                19.9.1.2.1. By Drug Coating

                19.9.1.2.2. By Indication

                19.9.1.2.3. By Artery Type

                19.9.1.2.4. By End User

        19.9.2. Indonesia Market Analysis

            19.9.2.1. Introduction

            19.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                19.9.2.2.1. By Drug Coating

                19.9.2.2.2. By Indication

                19.9.2.2.3. By Artery Type

                19.9.2.2.4. By End User

        19.9.3. Malaysia Market Analysis

            19.9.3.1. Introduction

            19.9.3.2. Market Analysis and Forecast, by Market Taxonomy

                19.9.3.2.1. By Drug Coating

                19.9.3.2.2. By Indication

                19.9.3.2.3. By Artery Type

                19.9.3.2.4. By End User

        19.9.4. Thailand Market Analysis

            19.9.4.1. Introduction

            19.9.4.2. Market Analysis and Forecast, by Market Taxonomy

                19.9.4.2.1. By Drug Coating

                19.9.4.2.2. By Indication

                19.9.4.2.3. By Artery Type

                19.9.4.2.4. By End User

20. Oceania Market 2012-2022 and Forecast 2022-2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    20.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Drug Coating

        20.3.3. By Indication

        20.3.4. By Artery Type

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Drug Coating

        20.4.3. By Indication

        20.4.4. By Artery Type

        20.4.5. By End User

    20.5. PESTLE Analysis

    20.6. Market Trends

    20.7. Key Market Participants – Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

    20.9. Country Level Analysis & Forecast

        20.9.1. Australia Market Analysis

            20.9.1.1. Introduction

            20.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                20.9.1.2.1. By Drug Coating

                20.9.1.2.2. By Indication

                20.9.1.2.3. By Artery Type

                20.9.1.2.4. By End User

        20.9.2. New Zealand Market Analysis

            20.9.2.1. Introduction

            20.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                20.9.2.2.1. By Drug Coating

                20.9.2.2.2. By Indication

                20.9.2.2.3. By Artery Type

                20.9.2.2.4. By End User

21. Middle East and Africa (MEA) Market Analysis 2012-2022 and Forecast 2023-2033

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2012-2022

    21.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023-2033

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Türkiye

            21.3.1.3. Israel

            21.3.1.4. South Africa

            21.3.1.5. North Africa

            21.3.1.6. Rest of Middle East and Africa

        21.3.2. By Drug Coating

        21.3.3. By Indication

        21.3.4. By Artery Type

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Drug Coating

        21.4.3. By Indication

        21.4.4. By Artery Type

        21.4.5. By End User

    21.5. PESTLE Analysis

    21.6. Market Trends

    21.7. Key Market Participants – Intensity Mapping

    21.8. Drivers and Restraints - Impact Analysis

    21.9. Country Level Analysis & Forecast

        21.9.1. GCC Countries Market Analysis

            21.9.1.1. Introduction

            21.9.1.2. Market Analysis and Forecast, by Market Taxonomy

                21.9.1.2.1. By Drug Coating

                21.9.1.2.2. By Indication

                21.9.1.2.3. By Artery Type

                21.9.1.2.4. By End User

        21.9.2. Türkiye Market Analysis

            21.9.2.1. Introduction

            21.9.2.2. Market Analysis and Forecast, by Market Taxonomy

                21.9.2.2.1. By Drug Coating

                21.9.2.2.2. By Indication

                21.9.2.2.3. By Artery Type

                21.9.2.2.4. By End User

        21.9.3. Israel Africa Market Analysis

            21.9.3.1. Introduction

            21.9.3.2. Market Analysis and Forecast, by Market Taxonomy

                21.9.3.2.1. By Drug Coating

                21.9.3.2.2. By Indication

                21.9.3.2.3. By Artery Type

                21.9.3.2.4. By End User

        21.9.4. South Africa Market Analysis

            21.9.4.1. Introduction

            21.9.4.2. Market Analysis and Forecast, by Market Taxonomy

                21.9.4.2.1. By Drug Coating

                21.9.4.2.2. By Indication

                21.9.4.2.3. By Artery Type

                21.9.4.2.4. By End User

        21.9.5. North Africa Market Analysis

            21.9.5.1. Introduction

            21.9.5.2. Market Analysis and Forecast, by Market Taxonomy

                21.9.5.2.1. By Drug Coating

                21.9.5.2.2. By Indication

                21.9.5.2.3. By Artery Type

                21.9.5.2.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis, by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Branding and Promotional Strategies, By Manufacturers

    23.3. Key Development Analysis

    23.4. Competition Deep Dive

        23.4.1. Abbott Laboratories

            23.4.1.1. Overview

            23.4.1.2. Product Portfolio

            23.4.1.3. Sales Footprint

            23.4.1.4. Key Financials

            23.4.1.5. SWOT Analysis

            23.4.1.6. Key Developments

            23.4.1.7. Strategy Overview

                23.4.1.7.1. Marketing Strategy

                23.4.1.7.2. Product Strategy

                23.4.1.7.3. Channel Strategy

        23.4.2. Boston Scientific Corporation

            23.4.2.1. Overview

            23.4.2.2. Product Portfolio

            23.4.2.3. Sales Footprint

            23.4.2.4. Key Financials

            23.4.2.5. SWOT Analysis

            23.4.2.6. Key Developments

            23.4.2.7. Strategy Overview

                23.4.2.7.1. Marketing Strategy

                23.4.2.7.2. Product Strategy

                23.4.2.7.3. Channel Strategy

        23.4.3. Cook Medical Inc.

            23.4.3.1. Overview

            23.4.3.2. Product Portfolio

            23.4.3.3. Sales Footprint

            23.4.3.4. Key Financials

            23.4.3.5. SWOT Analysis

            23.4.3.6. Key Developments

            23.4.3.7. Strategy Overview

                23.4.3.7.1. Marketing Strategy

                23.4.3.7.2. Product Strategy

                23.4.3.7.3. Channel Strategy

        23.4.4. MicroPort Scientific Corporation (Endovastec™)

            23.4.4.1. Overview

            23.4.4.2. Product Portfolio

            23.4.4.3. Sales Footprint

            23.4.4.4. Key Financials

            23.4.4.5. SWOT Analysis

            23.4.4.6. Key Developments

            23.4.4.7. Strategy Overview

                23.4.4.7.1. Marketing Strategy

                23.4.4.7.2. Product Strategy

                23.4.4.7.3. Channel Strategy

        23.4.5. Medtronic Plc.

            23.4.5.1. Overview

            23.4.5.2. Product Portfolio

            23.4.5.3. Sales Footprint

            23.4.5.4. Key Financials

            23.4.5.5. SWOT Analysis

            23.4.5.6. Key Developments

            23.4.5.7. Strategy Overview

                23.4.5.7.1. Marketing Strategy

                23.4.5.7.2. Product Strategy

                23.4.5.7.3. Channel Strategy

        23.4.6. Cardinal Health, Inc.

            23.4.6.1. Overview

            23.4.6.2. Product Portfolio

            23.4.6.3. Sales Footprint

            23.4.6.4. Key Financials

            23.4.6.5. SWOT Analysis

            23.4.6.6. Key Developments

            23.4.6.7. Strategy Overview

                23.4.6.7.1. Marketing Strategy

                23.4.6.7.2. Product Strategy

                23.4.6.7.3. Channel Strategy

        23.4.7. B. Braun Melsungen AG

            23.4.7.1. Overview

            23.4.7.2. Product Portfolio

            23.4.7.3. Sales Footprint

            23.4.7.4. Key Financials

            23.4.7.5. SWOT Analysis

            23.4.7.6. Key Developments

            23.4.7.7. Strategy Overview

                23.4.7.7.1. Marketing Strategy

                23.4.7.7.2. Product Strategy

                23.4.7.7.3. Channel Strategy

        23.4.8. BIOTRONIK SE & Co. KG

            23.4.8.1. Overview

            23.4.8.2. Product Portfolio

            23.4.8.3. Sales Footprint

            23.4.8.4. Key Financials

            23.4.8.5. SWOT Analysis

            23.4.8.6. Key Developments

            23.4.8.7. Strategy Overview

                23.4.8.7.1. Marketing Strategy

                23.4.8.7.2. Product Strategy

                23.4.8.7.3. Channel Strategy

        23.4.9. Becton, Dickinson and Company

            23.4.9.1. Overview

            23.4.9.2. Product Portfolio

            23.4.9.3. Sales Footprint

            23.4.9.4. Key Financials

            23.4.9.5. SWOT Analysis

            23.4.9.6. Key Developments

            23.4.9.7. Strategy Overview

                23.4.9.7.1. Marketing Strategy

                23.4.9.7.2. Product Strategy

                23.4.9.7.3. Channel Strategy

        23.4.10. W. L. Gore & Associates Inc.

            23.4.10.1. Overview

            23.4.10.2. Product Portfolio

            23.4.10.3. Sales Footprint

            23.4.10.4. Key Financials

            23.4.10.5. SWOT Analysis

            23.4.10.6. Key Developments

            23.4.10.7. Strategy Overview

                23.4.10.7.1. Marketing Strategy

                23.4.10.7.2. Product Strategy

                23.4.10.7.3. Channel Strategy

        23.4.11. Getinge AB

            23.4.11.1. Overview

            23.4.11.2. Product Portfolio

            23.4.11.3. Sales Footprint

            23.4.11.4. Key Financials

            23.4.11.5. SWOT Analysis

            23.4.11.6. Key Developments

            23.4.11.7. Strategy Overview

                23.4.11.7.1. Marketing Strategy

                23.4.11.7.2. Product Strategy

                23.4.11.7.3. Channel Strategy

        23.4.12. Terumo Corp

            23.4.12.1. Overview

            23.4.12.2. Product Portfolio

            23.4.12.3. Sales Footprint

            23.4.12.4. Key Financials

            23.4.12.5. SWOT Analysis

            23.4.12.6. Key Developments

            23.4.12.7. Strategy Overview

                23.4.12.7.1. Marketing Strategy

                23.4.12.7.2. Product Strategy

                23.4.12.7.3. Channel Strategy

        23.4.13. Kyoto Medical Planning Co Ltd

            23.4.13.1. Overview

            23.4.13.2. Product Portfolio

            23.4.13.3. Sales Footprint

            23.4.13.4. Key Financials

            23.4.13.5. SWOT Analysis

            23.4.13.6. Key Developments

            23.4.13.7. Strategy Overview

                23.4.13.7.1. Marketing Strategy

                23.4.13.7.2. Product Strategy

                23.4.13.7.3. Channel Strategy

        23.4.14. iVascular S.L.U

            23.4.14.1. Overview

            23.4.14.2. Product Portfolio

            23.4.14.3. Sales Footprint

            23.4.14.4. Key Financials

            23.4.14.5. SWOT Analysis

            23.4.14.6. Key Developments

            23.4.14.7. Strategy Overview

                23.4.14.7.1. Marketing Strategy

                23.4.14.7.2. Product Strategy

                23.4.14.7.3. Channel Strategy

        23.4.15. AMG International GmbH

            23.4.15.1. Overview

            23.4.15.2. Product Portfolio

            23.4.15.3. Sales Footprint

            23.4.15.4. Key Financials

            23.4.15.5. SWOT Analysis

            23.4.15.6. Key Developments

            23.4.15.7. Strategy Overview

                23.4.15.7.1. Marketing Strategy

                23.4.15.7.2. Product Strategy

                23.4.15.7.3. Channel Strategy

        23.4.16. ENDOCOR GmbH

            23.4.16.1. Overview

            23.4.16.2. Product Portfolio

            23.4.16.3. Sales Footprint

            23.4.16.4. Key Financials

            23.4.16.5. SWOT Analysis

            23.4.16.6. Key Developments

            23.4.16.7. Strategy Overview

                23.4.16.7.1. Marketing Strategy

                23.4.16.7.2. Product Strategy

                23.4.16.7.3. Channel Strategy

        23.4.17. Meril Life Sciences Pvt. Ltd.

            23.4.17.1. Overview

            23.4.17.2. Product Portfolio

            23.4.17.3. Sales Footprint

            23.4.17.4. Key Financials

            23.4.17.5. SWOT Analysis

            23.4.17.6. Key Developments

            23.4.17.7. Strategy Overview

                23.4.17.7.1. Marketing Strategy

                23.4.17.7.2. Product Strategy

                23.4.17.7.3. Channel Strategy

        23.4.18. Nano Therapeutics Pvt Ltd

            23.4.18.1. Overview

            23.4.18.2. Product Portfolio

            23.4.18.3. Sales Footprint

            23.4.18.4. Key Financials

            23.4.18.5. SWOT Analysis

            23.4.18.6. Key Developments

            23.4.18.7. Strategy Overview

                23.4.18.7.1. Marketing Strategy

                23.4.18.7.2. Product Strategy

                23.4.18.7.3. Channel Strategy

        23.4.19. Koninklijke Philips N.V.

            23.4.19.1. Overview

            23.4.19.2. Product Portfolio

            23.4.19.3. Sales Footprint

            23.4.19.4. Key Financials

            23.4.19.5. SWOT Analysis

            23.4.19.6. Key Developments

            23.4.19.7. Strategy Overview

                23.4.19.7.1. Marketing Strategy

                23.4.19.7.2. Product Strategy

                23.4.19.7.3. Channel Strategy

        23.4.20. REVA Medical

            23.4.20.1. Overview

            23.4.20.2. Product Portfolio

            23.4.20.3. Sales Footprint

            23.4.20.4. Key Financials

            23.4.20.5. SWOT Analysis

            23.4.20.6. Key Developments

            23.4.20.7. Strategy Overview

                23.4.20.7.1. Marketing Strategy

                23.4.20.7.2. Product Strategy

                23.4.20.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Table 01: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 02: Global Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 03: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 04: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 05: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 06: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Region

Table 07: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 08: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 09: North America Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 10: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 11: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 12: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 13: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 14: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 15: Latin America Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 16: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 17: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 18: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 19: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 20: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 21: Europe Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 22: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 23: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 24: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 25: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 26: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 27: East Asia Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 28: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 29: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 30: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 31: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 32: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 33: South Asia Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 34: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 35: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 36: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 37: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 38: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 39: Oceania Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 40: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 41: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 42: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Table 43: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis 2012-2022 and Forecast 2023–2033, by Country

Table 44: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Drug Coating

Table 45: Middle East & Africa Peripheral Drug Eluting Balloons Market Volume (Units) Analysis and Forecast 2012–2033, by Drug Coating

Table 46: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Indication

Table 47: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by Artery Type

Table 48: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis and Forecast 2012–2033, by End User

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 01: Global Peripheral Drug Eluting Balloons Market Volume (Units), 2012 – 2022

Figure 02: Global Peripheral Drug Eluting Balloons Market Volume (Units) & Y-o-Y Growth (%) Analysis,

Figure 03: Peripheral Drug Eluting Balloons, Pricing Analysis per unit (US$), in 2022

Figure 04: Peripheral Drug Eluting Balloons, Pricing Forecast per unit (US$), in 2033

Figure 05: Global Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 06: Global Peripheral Drug Eluting Balloons Market Forecast & Y-o-Y Growth, 2022–2033

Figure 07: Global Peripheral Drug Eluting Balloons Market Absolute $ Opportunity (US$ Mn) Analysis, 2022–2033

Figure 08: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Drug Coating

Figure 09: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Drug Coating

Figure 10: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Drug Coating

Figure 11: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Indication

Figure 12: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Indication

Figure 13: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Indication

Figure 14: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Artery Type

Figure 15: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Artery Type

Figure 16: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Artery Type

Figure 17: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by End User

Figure 18: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by End User

Figure 19: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by End User

Figure 20: Global Peripheral Drug Eluting Balloons Market Value Share (%) Analysis 2022 and 2033, by Region

Figure 21: Global Peripheral Drug Eluting Balloons Market Y-o-Y Growth (%) Analysis 2023-2033, by Region

Figure 22: Global Peripheral Drug Eluting Balloons Market Attractiveness Analysis 2023–2033, by Region

Figure 23: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 24: North America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 25: North America Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 26: North America Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 27: North America Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 28: North America Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 29: North America Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 30: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 31: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 32: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 33: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 34: North America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 35:U.S. Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 36: Global Vs. U.S. Growth Comparison

Figure 37:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 38:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 39:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 40:U.S. Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 41: Canada Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 42: Global Vs. Canada. Growth Comparison

Figure 43: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 44: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 45: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 46: Canada Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 47: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 48: Latin America Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 49: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 50: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 51: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 52: Latin America Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 53: Latin America Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 54: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 55: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 56: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 57: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 58: Latin America Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 59: Mexico Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 60: Global Vs Mexico Growth Comparison

Figure 61: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 62: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 63: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 64: Mexico Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 65: Brazil Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 66: Global Vs. Brazil. Growth Comparison

Figure 67: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 68: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 69: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 70: Brazil Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 71: Argentina Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 72: Global Vs Argentina Growth Comparison

Figure 73: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 74: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 75: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 76: Argentina Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 77: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 78: Europe Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 79: Europe Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 80: Europe Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 81: Europe Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 82: Europe Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 83: Europe Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 84: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 85: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 86: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 87: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 88: Europe Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 89: UK Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 90: Global Vs. UK Growth Comparison

Figure 91: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 92: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 93: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 94: UK Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 95: Germany Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 96: Global Vs. Germany Growth Comparison

Figure 97: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 98: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 99: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 100: Germany Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 101: Italy Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 102: Global Vs. Italy Growth Comparison

Figure 103: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 104: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 105: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 106: Italy Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 107: France Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 108: Global Vs France Growth Comparison

Figure 109: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 110: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 111: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 112: France Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 113: Spain Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 114: Global Vs Spain Growth Comparison

Figure 115: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 116: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 117: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 118: Spain Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 119: Russia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 120: Global Vs Russia Growth Comparison

Figure 121: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 122: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 123: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 124: Russia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 125: BENELUX Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 126: Global Vs BENELUX Growth Comparison

Figure 127: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 128: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 129: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 130: BENELUX Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 131: Nordics Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 132: Global Vs Nordics Growth Comparison

Figure 133: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 134: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 135: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 136: Nordics Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 137: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 138: East Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 139: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 140: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 141: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 142: East Asia Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 143: East Asia Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 144: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 145: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 146: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 147: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 148: East Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 149: China Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 150: Global Vs. China Growth Comparison

Figure 151: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 152: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 153: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 154: China Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 155: Japan Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 156: Global Vs. Japan Growth Comparison

Figure 157: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 158: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 159: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 160: Japan Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 161: South Korea Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 162: Global Vs South Korea Growth Comparison

Figure 163: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 164: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 165: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 166: South Korea Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 167: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 168: South Asia Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 169: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 170: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 171: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 172: South Asia Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 173: South Asia Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 174: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 175: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 176: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 177: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 178: South Asia Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 179: India Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 180: Global Vs. India Growth Comparison

Figure 181: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 182: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 183: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 184: India Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 185: Indonesia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 186: Global Vs. Indonesia Growth Comparison

Figure 187: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 188: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 189: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 190: Indonesia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 191: Malaysia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 192: Global Vs. Malaysia Growth Comparison

Figure 193: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 194: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 195: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 196: Malaysia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 197: Thailand Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 198: Global Vs. Thailand Growth Comparison

Figure 199: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 200: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 201: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 202: Thailand Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 203: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 204: Oceania Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 205: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 206: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 207: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 208: Oceania Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 209: Oceania Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 210: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 211: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 212: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 213: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 214: Oceania Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 215: Australia Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 216: Global Vs. Australia Growth Comparison

Figure 217: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 218: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 219: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 220: Australia Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 221: New Zealand Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 222: Global Vs New Zealand Growth Comparison

Figure 223: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 224: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 225: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 226: New Zealand Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 227: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Analysis, 2012–2022

Figure 228: Middle East & Africa Peripheral Drug Eluting Balloons Market Value (US$ Mn) Forecast, 2023-2033

Figure 229: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Drug Coating (2023 E)

Figure 230: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Indication (2023 E)

Figure 231: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Artery Type (2023 E)

Figure 232: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by End User (2023 E)

Figure 233: Middle East & Africa Peripheral Drug Eluting Balloons Market Value Share, by Country (2023 E)

Figure 234: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Drug Coating, 2023–2033

Figure 235: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Indication, 2023–2033

Figure 236: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Artery Type, 2023–2033

Figure 237: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by End User, 2023–2033

Figure 238: Middle East & Africa Peripheral Drug Eluting Balloons Market Attractiveness Analysis by Country, 2023–2033

Figure 239: GCC Countries Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 240: Global Vs GCC Countries Growth Comparison

Figure 241: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 242: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 243: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 244: GCC Countries Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 245: Türkiye Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 246: Global Vs. Türkiye Growth Comparison

Figure 247: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 248: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 249: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 250: Türkiye Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 251: Israel Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 252: Global Vs. Israel Growth Comparison

Figure 253: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 254: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 255: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 256: Israel Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 257: South Africa Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 258: Global Vs. South Africa Growth Comparison

Figure 259: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 260: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 261: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 262: South Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Figure 263: North Africa Peripheral Drug Eluting Balloons Market Value Proportion Analysis, 2022

Figure 264: Global Vs North Africa Growth Comparison

Figure 265: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Drug Coating, 2022 & 2033

Figure 266: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Indication, 2022 & 2033

Figure 267: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by Artery Type, 2022 & 2033

Figure 268: North Africa Peripheral Drug Eluting Balloons Market Share Analysis (%) by End User, 2022 & 2033

Google translate